Release Date: 06/29/2015
William Oh, MD, principal investigator of the Women & Infants/Brown Center of the Neonatal Research Network of the National Institute of Child Health and Human Development and neonatology professor at The Warren Alpert Medical School of Brown University, was honored by the Los Angeles Biomedical Research Institute (LA BioMed) as a “Legend” at the Institute’s reception in May. The Legends reception honors current and former LA BioMed researchers who have been leaders in their fields.
Dr. Oh is considered one of the founders of the field of neonatal medicine and has developed much of the current knowledge on newborn metabolism.
“This acknowledgment is an incredible testament to not only Dr. Oh, but to his colleagues at Women & Infants and Brown,” said Mark R. Marcantano, president and chief operating officer at Women & Infants Hospital. “The impact he has had on the field of neonatology is profound and immeasurable. We are extremely proud of his accomplishments.”
Originally trained in the Philippines where he received his medical degree, Dr. Oh came to the U.S. in 1958, for a pediatric residency at Michael Reese Hospital in Chicago, where he became chief resident and a research fellow in neonatology. From 1964 to 1966, he initiated a series of research projects at the Karolinska Institute in Stockholm that resulted in one of the first series of papers to examine neonatal blood pressure, neonatal blood volume, neonatal hemodynamics and neonatal renal function.
Dr. Oh became director of neonatology at Michael Reese Hospital in 1966, and in 1969 joined the faculty as chief of neonatology at Harbor General Hospital in California until 1974. In 1975, Dr. Oh left California to become pediatrician-in-chief of Women & Infants Hospital and professor of pediatrics and obstetrics at Brown University, where he was appointed chairman of the Department of Pediatrics in 1989. During this highly productive part of his career, Dr. Oh published virtually non-stop in a number of areas of neonatal medicine.
He continued his efforts toward understanding neonatal blood pressure, the role of acid-base balance upon abnormal fetal heart rate patterns and neonatal well-being, the effects of insensible water loss upon neonatal metabolism, nutritional well-being in neonates, neonatal glucose metabolism, intrauterine growth retardation, neonatal renal function, bilirubin toxicity, and many other issues.
Additional researchers honored with Dr. Oh include Dr. John E. Edwards, an infectious disease specialist at LA BioMed and the lead scientific founder of NovaDigm Therapeutics, and Dr. Samuel L. French, an LA BioMed researcher who has specialized in hepatopathology and alcoholic hepatitis for more than 60 years.
About LA BioMed
LA BioMed is one of the country’s leading non-profit independent biomedical research institutes. It has approximately 100 principal researchers conducting studies into improved treatments and therapies for cancer, inherited diseases, infectious disease, illnesses caused by environmental factors and more.
About Women & Infants Hospital
Women & Infants and Brown offer fellowship programs in gynecologic oncology, maternal-fetal medicine, urogynecology and reconstructive pelvic surgery, neonatal-perinatal medicine, pediatric and perinatal pathology, gynecologic pathology and cytopathology, and reproductive endocrinology and infertility. It is home to the nation’s first mother-baby perinatal psychiatric partial hospital, as well as the nation’s only fellowship program in obstetric medicine.
Women & Infants has been designated as a Breast Imaging Center of Excellence by the American College of Radiography; a Center of Excellence in Minimally Invasive Gynecology; a Center of Biomedical Research Excellence by the National Institutes of Health (NIH); and a Neonatal Resource Services Center of Excellence. It is one of the largest and most prestigious research facilities in high risk and normal obstetrics, gynecology and newborn pediatrics in the nation, and is a member of the National Cancer Institute’s Gynecologic Oncology Group and the Pelvic Floor Disorders Network.